Regulation of FOXP3 expression in myeloid cells in response to all-trans-retinoic acid, interleukin 2 and transforming growth factor β

Dev Comp Immunol. 2019 Jul:96:18-26. doi: 10.1016/j.dci.2019.02.019. Epub 2019 Mar 1.

Abstract

FoxP3 is a transcription factor essential for differentiation and function of T regulatory cells (Tregs). There are two major subsets of Tregs: natural Tregs (nTregs) generated in thymus and inducible Tregs (iTregs) produced in peripheral immune system. It has been documented that iTreg development is dependent on soluble mediators including interleukin 2 (IL2), transforming growth factor β (TGFβ) and all-trans-retinoic acid (ATRA). In our experiments we performed a gene expression array, followed by Real-time PCR experiments to study expression of genes regulated by ATRA in cells of myeloid origin. Our experiments revealed that ATRA alone, but also a cocktail of mediators consisting of IL2, TGFβ and ATRA, upregulate expression of FOXP3 gene in normal and leukemic myeloid cells. Our results indicate that signaling pathways which are used at the late steps of T cell differentiation, are also active in the cells of myeloid lineage.

Keywords: All-trans-retinoic acid; Blood cells; Differentiation; Interleukin 2; Lymphocytes; Monocytes; Myeloid leukemia; Transcription factors; Transforming growth factor β.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Forkhead Transcription Factors / metabolism*
  • HL-60 Cells
  • Humans
  • Interleukin-2 / metabolism*
  • Jurkat Cells
  • Myeloid Cells / drug effects
  • Myeloid Cells / metabolism*
  • Transforming Growth Factor beta / metabolism*
  • Tretinoin / pharmacology*
  • Up-Regulation / drug effects

Substances

  • FOXP3 protein, human
  • Forkhead Transcription Factors
  • IL2 protein, human
  • Interleukin-2
  • Transforming Growth Factor beta
  • Tretinoin